Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYBiogen Further Expands Presence in China with Approval of SPINRAZA® (nusinersen), the First and Only Treatment for Spinal Muscular AtrophyPREV STORYAnaptysBio Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Pipeline Updates
